Precision Medicine

I have a rare disease. We must rethink how we value care

Lynsey Chediak, the World Economic Forum’s Project Lead on Precision Medicine & Rare Diseases, was born with a rare condition called arthrogryposis. Image: Lynsey Chediak

Lynsey Chediak

Lead, Precision Medicine, Shaping the Future of Health and Healthcare, World Economic Forum

Share:

The Big Picture
Explore and monitor how Precision Medicine is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Precision Medicine

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

Precision MedicineHealth and Healthcare

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

What are clinical trials and how do they work?
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum